Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Revenue from Customers by Products) (Details)

v3.23.3
Revenue from Contracts with Customers (Revenue from Customers by Products) (Details) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 3,341,185 $ 9,602,195 $ 12,434,946 $ 36,765,721
FC2 [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 3,341,410 9,602,195 12,421,858 36,765,721
FC2, U.S. Prescription Channel [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 863,379 6,736,158 5,172,543 29,900,890
FC2, Global Public Health Sector [Member]        
Disaggregation of Revenue [Line Items]        
Revenues 2,478,031 $ 2,866,037 7,249,315 $ 6,864,831
Other [Member]        
Disaggregation of Revenue [Line Items]        
Revenues $ (225)   $ 13,088